American International Group’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-27,214
| Closed | -$132K | – | 3237 |
|
|
2020
Q1 | $132K | Sell |
27,214
-1,571
| -5% | -$10.2K | ﹤0.01% | 2148 |
|
|
2019
Q4 | $306K | Buy |
28,785
+482
| +2% | +$4.79K | ﹤0.01% | 1967 |
|
|
2019
Q3 | $295K | Buy |
28,303
+2,831
| +11% | +$37K | ﹤0.01% | 1946 |
|
|
2019
Q2 | $390K | Buy |
25,472
+1,087
| +4% | +$15.7K | ﹤0.01% | 1839 |
|
|
2019
Q1 | $313K | Buy |
24,385
+5,771
| +31% | +$65.2K | ﹤0.01% | 1968 |
|
|
2018
Q4 | $177K | Sell |
18,614
-143
| -0.8% | -$1.85K | ﹤0.01% | 2251 |
|
|
2018
Q3 | $311K | Buy |
18,757
+754
| +4% | +$12.1K | ﹤0.01% | 2152 |
|
|
2018
Q2 | $289K | Buy |
18,003
+1,025
| +6% | +$18.3K | ﹤0.01% | 2156 |
|
|
2018
Q1 | $260K | Buy |
16,978
+1,767
| +12% | +$27.5K | ﹤0.01% | 2129 |
|
|
2017
Q4 | $237K | Buy |
15,211
+73
| +0.5% | +$976 | ﹤0.01% | 2226 |
|
|
2017
Q3 | $168K | Buy |
15,138
+1,131
| +8% | +$10.6K | ﹤0.01% | 2380 |
|
|
2017
Q2 | $129K | Buy |
14,007
+3,464
| +33% | +$28.9K | ﹤0.01% | 2572 |
|
|
2017
Q1 | $90K | Buy |
10,543
+850
| +9% | +$7.75K | ﹤0.01% | 2646 |
|
|
2016
Q4 | $104K | Sell |
9,693
-26
| -0.3% | -$314 | ﹤0.01% | 2588 |
|
|
2016
Q3 | $105K | Buy |
9,719
+14
| +0.1% | +$114 | ﹤0.01% | 2566 |
|
|
2016
Q2 | $65.7K | Buy |
9,705
+554
| +6% | +$3.5K | ﹤0.01% | 2862 |
|
|
2016
Q1 | $43K | Hold |
9,151
| – | – | ﹤0.01% | 3953 |
|
|
2015
Q4 | $58K | Sell |
9,151
-16
| -0.2% | -$130 | ﹤0.01% | 3838 |
|
|
2015
Q3 | $81K | Buy |
9,167
+10
| +0.1% | +$105 | ﹤0.01% | 3638 |
|
|
2015
Q2 | $108K | Buy |
9,157
+1,893
| +26% | +$26.3K | ﹤0.01% | 3620 |
|
|
2015
Q1 | $105K | Hold |
7,264
| – | – | ﹤0.01% | 3535 |
|
|
2014
Q4 | $124K | Sell |
7,264
-288
| -4% | -$4.15K | ﹤0.01% | 3388 |
|
|
2014
Q3 | $94.1K | Sell |
7,552
-5
| -0.1% | -$62 | ﹤0.01% | 3603 |
|
|
2014
Q2 | $111K | Buy |
7,557
+520
| +7% | +$7.97K | ﹤0.01% | 3497 |
|
|
2014
Q1 | $143K | Buy |
7,037
+657
| +10% | +$15.9K | ﹤0.01% | 3142 |
|
|
2013
Q4 | $125K | Sell |
6,380
-52
| -0.8% | -$1.39K | ﹤0.01% | 3168 |
|
|
2013
Q3 | $291K | Buy |
+6,432
| New | +$210K | ﹤0.01% | 2384 |
|
American International Group's STML Position: Q2 2020 in Review
American International Group sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 27,214 shares — an estimated $132K sold.
American International Group first reported a position in STML in Q3 2013 and held it in 27 quarters. The position peaked at $390K in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- American International Group reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- American International Group sold 27,214 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $132K.
- American International Group first reported a position in Stemline Therapeutics, Inc. in Q3 2013 and held it in 27 quarters.
- American International Group's Stemline Therapeutics, Inc. position peaked at $390K in Q2 2019.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on American International Group's 13F filing for Q2 2020, filed 12 Aug 2020.